An Analysis of the Dealings of Johnson & Johnson with 298 Partnering Companies between 2000 and 2005.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26400 ) has announced the addition of Johnson & Johnson Deals Briefing to their offering. --Description Johnson & Johnson Deals briefing provides an in-depth view of the 282 deals made by Johnson & Johnson and its subsidiaries with 298 partnering companies between 2000 and 2005, in a clear and accessible PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format. format. Chapter 1: Company profile An overview of the company, including contact details, a summary of business and partnering interests, and a review of management Chapter 2: Financial data and deals overview A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector. Chapter 3: Summary of deals A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced. Chapter 4: List of deals A detailed listing of all the company's deals and alliances announced between January 2000 and July 2005. Every deal is fully categorized cat·e·go·rize tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es To put into a category or categories; classify. cat , includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed. --Scope The report contains: a brief company profile including subsidiary names financial information where disclosed a deals overview specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage a detailed listing of the company's deals and alliances --Key questions answered Johnson & Johnson Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in: identifying active partners tracking competitor activity benchmarking deals comparing the finances of different deal types. Johnson & Johnson Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Johnson & Johnson. --Forecasts, projections, market estimates This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector. --Who should buy the report This report is essential reading for board and executive management, and individuals in: business development licensing/partnering deal making business strategy marketing and promotion distribution and manufacturing (including contract services). Topics Covered Introduction About Partneringdesk Deals briefings Chapter 1: Company profile Chapter 2: Financial data and deals overview Chapter 3: Summary of deals Deals involving Johnson & Johnson by partner company Deals involving Johnson & Johnson by subsidiary Deals involving Johnson & Johnson by therapy focus Deals involving Johnson & Johnson by development stage Chapter 4: List of deals Glossary List of Tables Companies Mentioned 3-Dimensional Pharmaceuticals, AFx Inc, ALZA Corporation, Atrionix Inc, Biapharm, Biosense Webster Inc, Centocor, Cilag AG, Closure Medical, Codman & Shurtleff, Cook Group, Cordis Corporation, DePuy AcroMed, DePuy International, DePuy Orthopaedics orthopaedics Orthopedics , DePuy Spine, Egea Biosciences, ETHICON, Ethicon Endo-Surgery Ethicon Endo-Surgery, Inc., a subsidiary of Johnson & Johnson, is a company that designs and manufactures medical devices and surgical instruments with the intent of minimizing the invasiveness of surgery. Ethicon Endo-Surgery was part of Ethicon, Inc. , Guidant, Gynecare, Heartport Inc, Inverness Inverness, town, Scotland Inverness (ĭn'vərnĕs`), town (1991 pop. 39,736), Highland, N Scotland, on the Moray Firth at the mouth of the Ness River. Medical Innovations, Janssen Pharmaceutica Janssen Pharmaceutica, is a pharmaceutical company based in Beerse, Belgium, was established in 1953 by Dr. Paul Janssen. It was created not as a subsidiary of a chemical factory but solely with the aim of conducting pharmacological research. ,m Janssen-Cilag, Janssen-Ortho, Johnson & Johnson Consumer France SAS (1) (SAS Institute Inc., Cary, NC, www.sas.com) A software company that specializes in data warehousing and decision support software based on the SAS System. Founded in 1976, SAS is one of the world's largest privately held software companies. See SAS System. , Johnson & Johnson Merck Consumer, Pharmaceuticals, Johnson & Johnson Pharmaceutical Research & Development LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , Johnson & Johnson Vision Care Inc, LifeScan, Link Spine Group, McNeil Consumer Healthcare, McNeil Nutritionals McNeil Nutritionals, LLC is a division of Johnson & Johnson, and sells a range of products including Viactiv and the branded sucralose sweetener Splenda. It is based in Fort Washington, PA, USA. , Mitek Worldwide, Neutrogena Corporation, OraPharma, Orquest, Ortho Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. , Ortho-Clinical Diagnostics Ortho Clinical Diagnostics is a Johnson & Johnson company. It was created following Johnson and Johnson's acquiring of Ortho Diagnostic Systems in 1994, which was then merged with Johnson & Johnson Clinical Diagnostics in 1997. , Ortho-McNeil Pharmaceutical Ortho-McNeil Pharmaceutical, inc. is a pharmaceutical manufacturer based in Raritan, New Jersey, and a subsidiary of Johnson & Johnson. The company was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. Inc, RW Johnson Pharmaceutical Research Institute, Scios, TERAMed Inc, Therakos, Tibotec, TransForm Pharmaceuticals, Veridex, Virco Pharmaceuticals, VISTAKON, VISTAKONa Pharmaceuticals LLC, Xian-Janssen Pharmaceutical For more information visit http://www.researchandmarkets.com/reports/c26400 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion